Literature DB >> 11196009

Child development after maternal tocolysis with beta-sympathomimetic drugs.

M Pitzer1, M H Schmidt, G Esser, M Laucht.   

Abstract

The psycho-social development of both preterm and term children whose mothers reported tocolytic treatment was assessed at the ages of 2, 4.5, and 8 years. Term children exposed to tocolysis showed a higher rate of psychiatric disorders as well as poorer cognitive and motor performance than controls. In the preterm children no adverse impact of tocolysis could be found. The results are discussed concerning possible ways in which tocolytic treatment may influence child development. Restrictions because of the preliminary character of this study and the need of further prospective studies to clarify the developmental impact of tocolysis are also considered.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11196009     DOI: 10.1023/a:1026419720410

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  28 in total

1.  Predictors of developmental delay at 18 months and later school achievement problems.

Authors:  K Sonnander; M Claesson
Journal:  Dev Med Child Neurol       Date:  1999-03       Impact factor: 5.449

2.  Epidemiology and course of psychiatric disorders in school-age children--results of a longitudinal study.

Authors:  G Esser; M H Schmidt; W Woerner
Journal:  J Child Psychol Psychiatry       Date:  1990-01       Impact factor: 8.982

3.  Proto-oncogene fos (c-fos) expression in the heart.

Authors:  T Barka; H van der Noen; P A Shaw
Journal:  Oncogene       Date:  1987       Impact factor: 9.867

4.  [Tocolytic treatment with fenoterol. I. Prospective study of the effect of tocolysis on the condition of the newborn infant and early childhood development up to 4 years of age].

Authors:  I Gerhard; R Henninger; T von Holst; B Runnebaum; F Kubli
Journal:  Z Geburtshilfe Perinatol       Date:  1989 Jan-Feb

Review 5.  The smoking addiction of pregnant women and the consequences on their offspring's intellectual development.

Authors:  M Frydman
Journal:  J Environ Pathol Toxicol Oncol       Date:  1996       Impact factor: 3.567

Review 6.  Risks and complications of tocolysis.

Authors:  W C Hill
Journal:  Clin Obstet Gynecol       Date:  1995-12       Impact factor: 2.190

7.  Maternal smoking during pregnancy and psychopathology in offspring followed to adulthood.

Authors:  M M Weissman; V Warner; P J Wickramaratne; D B Kandel
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1999-07       Impact factor: 8.829

Review 8.  Long-term developmental outcomes of low birth weight infants.

Authors:  M Hack; N K Klein; H G Taylor
Journal:  Future Child       Date:  1995

9.  Long-term follow-up of children prenatally exposed to ritodrine.

Authors:  M Hadders-Algra; B C Touwen; H J Huisjes
Journal:  Br J Obstet Gynaecol       Date:  1986-02

10.  Language development of term and preterm children during the first five years of life.

Authors:  R H Largo; L Molinari; L Comenale Pinto; M Weber; G Duc
Journal:  Dev Med Child Neurol       Date:  1986-06       Impact factor: 5.449

View more
  11 in total

1.  In utero exposure to β-2-adrenergic receptor agonist and attention-deficit/hyperactivity disorder in children.

Authors:  Hong Liang; Jianping Chen; Maohua Miao; Jakob Christensen; Søren Dalsgaard; Wei Yuan; Jiong Li
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-02-09       Impact factor: 4.785

2.  Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-16       Impact factor: 3.763

3.  Developmental neurotoxicity resulting from pharmacotherapy of preterm labor, modeled in vitro: Terbutaline and dexamethasone, separately and together.

Authors:  Theodore A Slotkin; Samantha Skavicus; Frederic J Seidler
Journal:  Toxicology       Date:  2018-03-07       Impact factor: 4.221

4.  Absence of neurotoxicity with medicinal grade terbutaline in the rat model.

Authors:  Michelle Y Owens; Kedra L Wallace; Naila Mamoon; Josephine Wyatt-Ashmead; William A Bennett
Journal:  Reprod Toxicol       Date:  2011-01-22       Impact factor: 3.143

Review 5.  Prenatal exposure to drugs: effects on brain development and implications for policy and education.

Authors:  Barbara L Thompson; Pat Levitt; Gregg D Stanwood
Journal:  Nat Rev Neurosci       Date:  2009-03-11       Impact factor: 34.870

6.  Developmental exposure to terbutaline and chlorpyrifos, separately or sequentially, elicits presynaptic serotonergic hyperactivity in juvenile and adolescent rats.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2007-05-11       Impact factor: 4.077

Review 7.  Pleiotropic effects of neurotransmission during development: modulators of modularity.

Authors:  Barbara L Thompson; Gregg D Stanwood
Journal:  J Autism Dev Disord       Date:  2008-07-22

8.  Benzo(a)pyrene triggers desensitization of β2-adrenergic pathway.

Authors:  Abdullah Mayati; Normand Podechard; Manuelle Rineau; Lydie Sparfel; Dominique Lagadic-Gossmann; Olivier Fardel; Eric Le Ferrec
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

9.  Risk of childhood cerebral palsy following prenatal exposure to ß2-adrenergic receptor agonist: A nationwide cohort study.

Authors:  Lin Li; Ziliang Wang; Hong Liang; Fen Yang; Wei Yuan; Bizu Gelaye; Yongfu Yu; Maohua Miao; Mette Nørgaard; Jiong Li
Journal:  PLoS One       Date:  2018-08-16       Impact factor: 3.240

10.  Association between Beta-Sympathomimetic Tocolysis and Risk of Autistic Spectrum Disorders, Behavioural and Developmental Outcome in Toddlers.

Authors:  Mengühan Araz Altay; Işık Görker; Rakhshanda Aslanova; Leyla Bozatlı; Nesrin Turan; Petek Balkanlı Kaplan
Journal:  Open Access Maced J Med Sci       Date:  2017-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.